“Lebrikizumab Improves Atopic Dermatitis in Adult and Adolescent Patients With Skin of Color: 16-Week Results From the ADmirable Study”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 1, Jan. 2025, p. s515, https://doi.org/10.25251/skin.9.supp.515.